An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors ; day:14 ; month:5 ; year:2019 ; pages:1-10
Supportive care in cancer ; (14.5.2019), 1-10
- Urheber
-
O’Reilly, Aine
Hughes, Peta
Mann, Jasmine
Lai, Zhuangming
Teh, Jhia Jiat
Mclean, Emma
Edmonds, Kim
Lingard, Karla
Chauhan, Dharmisha
Lynch, Joanna
Au, Lewis
Ludlow, Aileen
Pattison, Natalie
Wiseman, Theresa
Turajlic, Samra
Gore, Martin
Larkin, James
Husson, Olga
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-019-04818-w
- URN
-
urn:nbn:de:101:1-2019062500281951874655
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- O’Reilly, Aine
- Hughes, Peta
- Mann, Jasmine
- Lai, Zhuangming
- Teh, Jhia Jiat
- Mclean, Emma
- Edmonds, Kim
- Lingard, Karla
- Chauhan, Dharmisha
- Lynch, Joanna
- Au, Lewis
- Ludlow, Aileen
- Pattison, Natalie
- Wiseman, Theresa
- Turajlic, Samra
- Gore, Martin
- Larkin, James
- Husson, Olga
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
A survivor with unexplained chest scars
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury
SURVIVOR
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Long survivor family with HIV infection. Case presentation
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report